Mirikizumab for Crohn's disease

被引：0
|
作者：
Baker, Holly
机构：
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2022年 / 7卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [31] Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate to severe Crohn's disease: Results from the phase 3 VIVID 1 study
    Jairath, V.
    Sands, B. E.
    Bossuyt, P.
    Farraye, F.
    Ferrante, M.
    Hisamatsu, T.
    Kaser, A.
    Kierkus, J.
    Laharie, D.
    Reinisch, W.
    Siegmund, B.
    Bragg, S. M.
    Hon, E.
    Lin, Z.
    Lopes, M. Ugolini
    Morris, N.
    Protic, M.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I62 - I64
  • [32] Challenges in Crohn's disease: Complex perianal Crohn's disease
    Lightner, Amy L.
    SEMINARS IN COLON AND RECTAL SURGERY, 2020, 31 (02)
  • [33] Crohn's disease: Postsurgical, Crohn's disease for some years
    Rutgeerts, P
    IBD - THE PATIENT IN FOCUS, 1997, 19 (01): : 123 - 123
  • [34] Impact of mirikizumab therapy on histological measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn's disease
    Leong, R.
    Pai, R.
    De Hertogh, G.
    Reinisch, W.
    Harpaz, N.
    Feagan, B. G.
    Agada, N.
    Pollack, P.
    Chan, L-S
    Protic, M.
    Magro, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 131 - 131
  • [35] Challenges in Crohn's disease: Crohn's disease involving the duodenum
    Yamamoto, Takayuki
    Spinelli, Antonino
    Kotze, Paulo Gustavo
    SEMINARS IN COLON AND RECTAL SURGERY, 2020, 31 (02)
  • [36] CROHN'S DISEASE Bacterial clearance in Crohn's disease pathogenesis
    Fava, Francesca
    Danese, Silvio
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (03) : 126 - 128
  • [37] Improvement in Fatigue With Mirikizumab Therapy Is Associated With Improvements in Patient-Reported Outcomes in Patients With Moderately-to-Severely Active Crohn's Disease
    Regueiro, Miguel
    Fischer, Monika
    Rubin, David T.
    Hibi, Toshifumi
    Bossuyt, Peter
    Juillerat, Pascal
    Pollack, Paul
    Zhou, Xian
    Protic, Marijana
    Gibble, Theresa Hunter
    Chan, Lai-Shan
    Carlier, Hilde
    Hindryckx, Pieter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S557 - S558
  • [38] EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH CROHN'S DISEASE: 104-WEEK EXTENSION RESULTS FROM A PHASE 2 RANDOMIZED CONTROLLED TRIAL
    Kaser, A.
    Sands, B. E.
    Protic, M.
    Peyrin-Biroulet, L.
    Lin, Z.
    Hozak, R.
    Jairath, V
    Carlier, H.
    Hon, E.
    Fischer, M.
    Caprioli, F.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S137 - S138
  • [39] Improvement in fatigue with mirikizumab therapy is associated with clinical remission and pain improvements but not with endoscopic response in patients with moderately to severely active Crohn's disease
    Reguiero, Miguel
    Fischer, Monika
    Rubin, David T.
    Hibi, Toshifumi
    Bossuyt, Peter
    Juillerat, Pascal
    Pollack, Paul
    Zhou, Xian
    Protic, Marijana
    Hunter, Theresa
    Chan, Lai Shan
    Cartier, Hilde
    Hindryckx, Pieter
    SWISS MEDICAL WEEKLY, 2023, 153 : 27S - 27S
  • [40] Crohn's disease
    Williams, CN
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1999, 13 (10): : 801 - 802
12345